icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
Back grey_arrow_rt.gif
 
 
 
Resistance Analyses of Bictegravir/Emtricitabine/Tenofovir Alafenamide Switch Studies
 
 
  Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
 
Kristen Andreatta, Madeleine Willkom, Ross Martin, Silvia Chang, Hal Martin, Hiba Graham, Erin Quirk, and Kirsten L. White
Gilead Sciences, Inc., Foster City, CA

0326181

0326182

0326183

0326184

0326185

0326186

0326187

0326188

0326189

03261810

03261811

03261812

03261813

03261814